|
Volumn 65, Issue 12, 2006, Pages 1665-1666
|
Farber's disease without central nervous system involvement: Bone-marrow transplantation provides a promising new approach [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYLSPHINGOSINE DEACYLASE;
ANTIINFLAMMATORY AGENT;
BUSULFAN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
STEROID;
THYMOCYTE ANTIBODY;
ANALGESIA;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
CENTRAL NERVOUS SYSTEM;
CLINICAL FEATURE;
FARBER DISEASE;
GRAFT VERSUS HOST REACTION;
HUMAN;
JUVENILE RHEUMATOID ARTHRITIS;
LETTER;
NEUROTOXICITY;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
SURGICAL TECHNIQUE;
VEIN OCCLUSION;
ADULT;
CERAMIDE TRIHEXOSIDASE;
CHILD, PRESCHOOL;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LYSOSOMAL STORAGE DISEASES;
MALE;
TREATMENT OUTCOME;
|
EID: 33751262990
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.2005.048322 Document Type: Letter |
Times cited : (17)
|
References (7)
|